For the ACT program design using innovative and adaptive methodology to find a safe, effective treatment to slow the progression of COVID-19 across 80 sites in 8 countries over 6 months.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. John EikelboomResearch Location
CanadaLead Research Institution
McMaster UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
For the ACT program design using innovative and adaptive methodology to find a safe, effective treatment to slow the progression of COVID-19 across 80 sites in 8 countries over 6 months.